Nasus Pharma Ltd. (NSRX) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Tel Aviv, Israel. The current CEO is Dan Teleman.
NSRX has IPO date of 2025-08-13, 2 full-time employees, listed on the NYSE, a market capitalization of $19.03M.
No company description available.
